Works by Begna, Kebede H.

Results: 53
    1

    Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 6, p. 1010, doi. 10.1002/ajh.27670
    By:
    • Fathima, Saubia;
    • Abdelmagid, Maymona;
    • Alsugair, Ali;
    • Begna, Kebede H.;
    • Al‐Kali, Aref;
    • Mangaonkar, Abhishek A.;
    • Pardanani, Animesh D.;
    • Patnaik, Mrinal M.;
    • Zepeda Mendoza, Cinthya J.;
    • He, Rong;
    • Reichard, Kaaren K.;
    • Badar, Talha;
    • Foran, James M.;
    • Palmer, Jeanne;
    • Loscocco, Giuseppe G.;
    • Guglielmelli, Paola;
    • Vannucchi, Alessandro M.;
    • Orazi, Attilio;
    • Arber, Daniel A.;
    • Hiwase, Devendra
    Publication type:
    Article
    2

    Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00891-x
    By:
    • Abdelmagid, Maymona G.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Begna, Kebede H.;
    • Hogan, William J.;
    • Patnaik, Mirinal S.;
    • Hashmi, Shahrukh K.;
    • Elliott, Michelle A.;
    • Alkhateeb, Hassan;
    • Karrar, Omer S.;
    • Fleti, Farah;
    • Elnayir, Mohammed H.;
    • Rivera, Candido E.;
    • Murthy, Hemant S.;
    • Foran, James M.;
    • Kharfan-Dabaja, Mohamed A.;
    • Badar, Talha;
    • Viswanatha, David S.;
    • Reichard, Kaaren K.;
    • Gangat, Naseema
    Publication type:
    Article
    3

    Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00812-y
    By:
    • Abdallah, Mostafa;
    • McCullough, Kristen;
    • Ilyas, Rimal;
    • Begna, Kebede H.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Mangaonkar, Abhishek;
    • Alkhateeb, Hassan;
    • Shah, Mithun V.;
    • Elliott, Michelle A.;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Yi, Cecilia Arana;
    • Sproat, Lisa;
    • Pardanani, Animesh;
    • Patnaik, Mrinal M.;
    • Olteanu, Horatiu;
    • Ketterling, Rhett P.
    Publication type:
    Article
    4

    Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

    Published in:
    2023
    By:
    • Abdallah, Mostafa;
    • McCullough, Kristen;
    • Ilyas, Rimal;
    • Begna, Kebede H.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Mangaonkar, Abhishek;
    • Alkhateeb, Hassan;
    • Shah, Mithun V.;
    • Elliott, Michelle A.;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Yi, Cecilia Arana;
    • Sproat, Lisa;
    • Pardanani, Animesh;
    • Patnaik, Mrinal M.;
    • Olteanu, Horatiu;
    • Ketterling, Rhett P.
    Publication type:
    Letter
    5
    6

    Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00622-8
    By:
    • Mangaonkar, Abhishek A.;
    • Lasho, Terra L.;
    • Ketterling, Rhett P.;
    • Reichard, Kaaren K.;
    • Gangat, Naseema;
    • Al-Kali, Aref;
    • Begna, Kebede H.;
    • Pardanani, Animesh;
    • Al Ali, Najla H.;
    • Talati, Chetasi;
    • Sallman, David;
    • Padron, Eric;
    • Patnaik, Mrinal M.;
    • Tefferi, Ayalew;
    • Komrokji, Rami
    Publication type:
    Article
    7

    Mayo Clinic experience with 1123 adults with acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00435-1
    By:
    • Begna, Kebede H.;
    • Ali, Walid;
    • Naseema Gangat;
    • Elliott, Michelle A.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Christopher Hook, C.;
    • Wolanskyj-Spinner, Alexandra P.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Zblewski, Darci L.;
    • Chen, Dong;
    • He, Rong;
    • Viswanatha, David;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article
    8
    9
    10

    Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1592, doi. 10.1080/10428194.2020.1737684
    By:
    • Bubik, Rachel J.;
    • Barth, Dylan M.;
    • Hook, Christopher;
    • Wolf, Robert C.;
    • Muth, Jessica M.;
    • Mara, Kristin;
    • Patnaik, Mrinal S.;
    • Pruthi, Rajiv K.;
    • Marshall, Ariela L.;
    • Litzow, Mark R.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Shah, Mithun V.;
    • Begna, Kebede H.;
    • Alkhateeb, Hassan;
    • Pardanani, Animesh;
    • Ashrani, Aneel A.;
    • Call, Timothy G.;
    • Rivera, Candido E.;
    • Camoriano, John K.
    Publication type:
    Article
    11

    Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 990, doi. 10.1080/10428194.2018.1509318
    By:
    • Miller, Kevin C.;
    • Al-Kali, Aref;
    • Shah, Mithun V.;
    • Hogan, William J.;
    • Elliott, Michelle A.;
    • Begna, Kebede H.;
    • Gangat, Naseema;
    • Patnaik, Mrinal M.;
    • Viswanatha, David S.;
    • He, Rong;
    • Greipp, Patricia T.;
    • Sproat, Lisa Z.;
    • Foran, James M.;
    • Litzow, Mark R.;
    • Alkhateeb, Hassan B.
    Publication type:
    Article
    12
    13

    Comparison of complication rates of Hickman<sup>®</sup> catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 6, p. 1263, doi. 10.3109/10428194.2012.742520
    By:
    • Lim, Ming Y.;
    • Al-Kali, Aref;
    • Ashrani, Aneel A.;
    • Begna, Kebede H.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Hook, C. Christopher;
    • Kaufmann, Scott H.;
    • Letendre, Louis;
    • Litzow, Mark R.;
    • Patnaik, Mrinal S.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew;
    • Wolanskyj, Alexandra P.;
    • Grill, Diane E.;
    • Pruthi, Rajiv K.
    Publication type:
    Article
    14

    TP53 Mutations in Myeloproliferative Neoplasms: Context‐Dependent Evaluation of Prognostic Relevance.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 4, p. 552, doi. 10.1002/ajh.27609
    By:
    • Tefferi, Ayalew;
    • Abdelmagid, Maymona;
    • Loscocco, Giuseppe G.;
    • Fathima, Saubia;
    • Begna, Kebede H.;
    • Al‐Kali, Aref;
    • Foran, James;
    • Palmer, Jeanne;
    • Badar, Talha;
    • Patnaik, Mrinal M.;
    • Reichard, Kaaren K.;
    • He, Rong;
    • Zepeda Mendoza, Cinthya J.;
    • Shah, Mithun;
    • Orazi, Attilio;
    • Arber, Daniel A.;
    • Pardanani, Animesh;
    • Vannucchi, Alessandro M.;
    • Hiwase, Devendra;
    • Gangat, Naseema
    Publication type:
    Article
    15

    Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 2, p. 260, doi. 10.1002/ajh.27564
    By:
    • Gangat, Naseema;
    • Elbeih, Azeem;
    • Ghosoun, Nour;
    • McCullough, Kristen;
    • Aperna, Fnu;
    • Johnson, Isla M.;
    • Abdelmagid, Maymona;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle;
    • Mangaonkar, Abhishek;
    • Matin, Aasiya;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh
    Publication type:
    Article
    16

    Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
    By:
    • Karrar, Omer;
    • Abdelmagid, Maymona;
    • Rana, Masooma;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Elliott, Michelle A.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant;
    • Foran, James
    Publication type:
    Article
    17

    Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
    By:
    • Gangat, Naseema;
    • Karrar, Omer;
    • Iftikhar, Moazah;
    • McCullough, Kristen;
    • Johnson, Isla M.;
    • Abdelmagid, Maymona;
    • Abdallah, Mostafa;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan B.;
    • Begna, Kebede H.;
    • Mangaonkar, Abhishek;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Badar, Talha;
    • Murthy, Hemant
    Publication type:
    Article
    18
    19

    TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845
    By:
    • Fleti, Farah;
    • Chan, Onyee;
    • Singh, Amritpal;
    • Abdelmagid, Maymona G.;
    • Al‐Kali, Aref;
    • Elliott, Michelle A.;
    • Begna, Kebede H.;
    • Foran, James M.;
    • Badar, Talha;
    • Khera, Nandita;
    • Al Ali, Najla H.;
    • Padron, Eric;
    • Sallman, David A.;
    • Shah, Mithun;
    • Hiwase, Devendra;
    • Pardanani, Animesh;
    • Arber, Daniel A.;
    • Orazi, Attilio;
    • Reichard, Kaaren K.;
    • He, Rong
    Publication type:
    Article
    20
    21
    22
    23

    A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1127, doi. 10.1002/ajh.26630
    By:
    • Tefferi, Ayalew;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan;
    • Shah, Mithun;
    • Patnaik, Mrinal S.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Hook, Christopher C.;
    • Mangaonkar, Abhishek;
    • Viswanatha, David;
    • Chen, Dong;
    • Pardanani, Animesh;
    • Ketterling, Rhett P.;
    • DiNardo, Courtney D.;
    • Kadia, Tapan M.;
    • Ravandi, Farhad;
    • Sasaki, Koji;
    • Begna, Kebede H.
    Publication type:
    Article
    24

    Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 8, p. 1013, doi. 10.1002/ajh.26589
    By:
    • Shah, Mithun Vinod;
    • Chhetri, Rakchha;
    • Dholakia, Ruchita;
    • Kok, Chung H.;
    • Gangat, Naseema;
    • Alkhateeb, Hassan B.;
    • Al‐Kali, Aref;
    • Patnaik, Mrinal M.;
    • Baranwal, Anmol;
    • Greipp, Patricia T.;
    • He, Rong;
    • Begna, Kebede H.;
    • Tiong, Ing Soo;
    • Wei, Andrew H.;
    • Hiwase, Devendra
    Publication type:
    Article
    25

    Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 6, p. E214, doi. 10.1002/ajh.26539
    By:
    • Gangat, Naseema;
    • McCullough, Kristen;
    • Johnson, Isla;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Alkhateeb, Hassan;
    • Mangaonkar, Abhishek;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Sproat, Lisa;
    • Arana Yi, Cecilia Y.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew
    Publication type:
    Article
    26
    27

    Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
    By:
    • Gangat, Naseema;
    • Guglielmelli, Paola;
    • Szuber, Natasha;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Al‐Kali, Aref;
    • Foran, James M.;
    • Palmer, Jeanne M.;
    • Alkhateeb, Hassan;
    • Elliott, Michelle A.;
    • Hanson, Curtis A.;
    • Pardanani, Animesh;
    • Mannelli, Francesco;
    • Vannucchi, Alessandro M.;
    • Tefferi, Ayalew
    Publication type:
    Article
    28

    Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 4, p. E108, doi. 10.1002/ajh.26112
    By:
    • Begna, Kebede H.;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Hook, C. Christopher;
    • Wolanskyj, Alexandra P.;
    • Elliott, Michelle A.;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article
    29

    Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like (Philadelphia chromosome like) B‐acute lymphoblastic leukemia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. E68, doi. 10.1002/ajh.25729
    By:
    • Anagnostou, Theodora;
    • Knudson, Ryan A.;
    • Pearce, Kathryn E.;
    • Meyer, Reid G.;
    • Pitel, Beth A.;
    • Peterson, Jess F.;
    • Baughn, Linda B.;
    • Reichard, Kaaren K.;
    • Ketterling, Rhett P.;
    • Kloft‐Nelson, Sara M.;
    • Knutson, Darlene L.;
    • Khan, Shakila P.;
    • Gangat, Naseema;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Wolanskyj, Alexandra;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Elliott, Michelle;
    • Pardanani, Animesh
    Publication type:
    Article
    30
    31

    A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3‐ITD mutational status.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 12, p. E401, doi. 10.1002/ajh.25290
    By:
    • Begna, Kebede H.;
    • Ali, Walid;
    • Gangat, Naseema;
    • Elliott, Michelle A.;
    • Al‐Kali, Aref;
    • Litzow, Mark R.;
    • Hook, C. Christopher;
    • Wolanskyj, Alexandra P.;
    • Hogan, William J.;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Zblewski, Darci L.;
    • Chen, Dong;
    • He, Rong;
    • Viswanatha, David;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Tefferi, Ayalew
    Publication type:
    Article
    32
    33

    High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 8, p. E164, doi. 10.1002/ajh.24765
    By:
    • Ravindran, Aishwarya;
    • Sankaran, Janani;
    • Jacob, Eapen K.;
    • Kreuter, Justin D.;
    • Hook, C. Christopher;
    • Gertz, Morie A.;
    • Call, Timothy G.;
    • Pruthi, Rajiv K.;
    • Litzow, Mark R.;
    • Wolanskyj, Alexandra P.;
    • Hogan, William J.;
    • Ashrani, Aneel A.;
    • Begna, Kebede H.;
    • Marshall, Ariela L.;
    • Kyle, Robert A.;
    • Kay, Neil E.;
    • Go, Ronald S.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    TP53 variant allele frequency and therapy‐related setting independently predict survival in myelodysplastic syndromes with del(5q).

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 4, p. 1243, doi. 10.1111/bjh.19247
    By:
    • Tefferi, Ayalew;
    • Fleti, Farah;
    • Chan, Onyee;
    • Al Ali, Najla H.;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Foran, James M.;
    • Badar, Talha;
    • Khera, Nandita;
    • Shah, Mithun;
    • Hiwase, Devendra;
    • Padron, Eric;
    • Sallman, David A.;
    • Pardanani, Animesh;
    • Arber, Daniel A.;
    • Orazi, Attilio;
    • Reichard, Kaaren K.;
    • He, Rong;
    • Ketterling, Rhett P.;
    • Gangat, Naseema
    Publication type:
    Article
    40

    The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.

    Published in:
    British Journal of Haematology, 2023, v. 202, n. 2, p. 279, doi. 10.1111/bjh.18850
    By:
    • Gurney, Mark;
    • Chekkaf, Ismahene;
    • Baranwal, Anmol;
    • Basmaci, Rami;
    • Katamesh, Bahga;
    • Greipp, Patricia;
    • Foran, James M.;
    • Badar, Talha;
    • Mangaonkar, Abhishek A.;
    • Begna, Kebede H.;
    • Gangat, Naseema;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Shah, Mithun V.;
    • Viswanatha, David S.;
    • He, Rong;
    • Alkhateeb, Hassan B.;
    • Al‐Kali, Aref
    Publication type:
    Article
    41

    Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real‐world experience.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 4, p. e54, doi. 10.1111/bjh.18284
    By:
    • Gangat, Naseema;
    • McCullough, Kristen;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Alkhateeb, Hassan;
    • Mangaonkar, Abhishek;
    • Foran, James M.;
    • Palmer, Jeanne M.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 23, p. 4421, doi. 10.1002/cncr.33828
    By:
    • Kantarjian, Hagop M.;
    • Begna, Kebede H.;
    • Altman, Jessica K.;
    • Goldberg, Stuart L.;
    • Sekeres, Mikkael A.;
    • Strickland, Stephen A.;
    • Arellano, Martha L.;
    • Claxton, David F.;
    • Baer, Maria R.;
    • Gautier, Marc;
    • Berman, Ellin;
    • Seiter, Karen;
    • Solomon, Scott R.;
    • Schiller, Gary J.;
    • Luger, Selina M.;
    • Butrym, Aleksandra;
    • Gaidano, Gianluca;
    • Thomas, Xavier G.;
    • Montesinos, Pau;
    • Rizzieri, David A.
    Publication type:
    Article
    49
    50